Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Patient Comfort After Two Anesthetic Protocols for Injections Into the Eye

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Has required repeat Ranibizumab injections and has had at least 3 injections prior to recruitment~* Informed consent~* Age ≥ 18 years~* Clinical need for a therapeutic ranibizumab intravitreal injection regardless of the medical indication~* Able to understand and read English~Exclusion Criteria:~* Pregnancy (positive pregnancy test)~* Mental disability~* Prisoners~* Patients with fluctuating or impaired decision-making capacity~* Inability to comply with study or follow-up procedures~* Previous reaction to the same drug class

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 4% lidocaine (Type: EXPERIMENTAL): Eyes were anesthetized with 0.5% proparacaine and then with three cotton swabs soaked in 4% liquid lidocaine applied with moderate pressure to the site of the injection inferotemporally to the limbus. Each participant was assigned to have this prep during one of the consecutive study visits if unilateral or in one eye if patient requires bilateral injections given the same day
- 3.5% ophthalmic lidocaine gel (Type: EXPERIMENTAL): Eye was anesthetized with 0.5% proparacaine and then with 3.5% ophthalmic lidocaine gel applied to the surface of the eye. Each participant was randomly assigned to receive this preparation during one of two consecutive intravitreal injection (if unilateral disease) or in one eye if requiring bilateral injections given on the same day.

Based on this trial design, predict the completion outcome and termination type (if applicable).